US drug shortages reach all-time high: Cancer and diabetes patients waiting 'deadly' amount of time for lifesaving drugs
The shortage of life-sustaining drugs for cancer, diabetes, and ADHD that has plagued hospitals and patients for years has now reached its peak with 323 medicines officially in short supply. (Source: the Mail online | Health)
Source: the Mail online | Health - April 11, 2024 Category: Consumer Health News Source Type: news

Short, Frequent Walks Improve Cardiovascular Profile in T1D Short, Frequent Walks Improve Cardiovascular Profile in T1D
Short breaks with light-intensity walks to interrupt long sitting hours improved postprandial vascular inflammatory biomarker levels in people with type 1 diabetes.Medscape Medical News (Source: Medscape Diabetes Headlines)
Source: Medscape Diabetes Headlines - April 11, 2024 Category: Endocrinology Tags: Diabetes & Endocrinology Clinical Summary Source Type: news

How to Talk to Your Family About Their Heart Health History
Hypertrophic obstructive cardiomyopathy (HOCM) is the most common genetic heart disease, affecting about 1 in every 500 people, according to the American Heart Association (AHA). In people with HOCM, genetic variants cause the heart’s walls to thicken and stiffen, blocking blood from flowing freely from the left ventricle to the aorta. This, in turn, results in shortness of breath and chest pain (especially during physical activity), abnormal heart rhythms, lightheadedness, dizziness, and fainting, and can worsen over time. [time-brightcove not-tgx=”true”] If a parent has HOCM, offspring have a 50% ch...
Source: TIME: Health - April 11, 2024 Category: Consumer Health News Authors: Sarah Klein Tags: Uncategorized Evergreen freelance healthscienceclimate Source Type: news

Speedy Eating and Late-Night Meals May Take a Toll on Health Speedy Eating and Late-Night Meals May Take a Toll on Health
A growing body of evidence shows that it ' s not just what and how much you eat that influence your health. How fast and when you eat also play a role.Medscape Medical News (Source: Medscape Diabetes Headlines)
Source: Medscape Diabetes Headlines - April 11, 2024 Category: Endocrinology Tags: Gastroenterology News Source Type: news

SGLT2 Inhibitors Reduce Anemia Risk in Concomitant T2D, CKD SGLT2 Inhibitors Reduce Anemia Risk in Concomitant T2D, CKD
Initiating treatment with SGLT2 inhibitors vs GLP-1 RAs was linked to a 19% reduced risk for composite anemia outcomes in patients with T2D and CKD stages I-III.Medscape Medical News (Source: Medscape Diabetes Headlines)
Source: Medscape Diabetes Headlines - April 11, 2024 Category: Endocrinology Tags: Diabetes & Endocrinology Clinical Summary Source Type: news

This outdated diabetes drug still has something to offer
Thiazolidinediones (TZDs) are a class of drug that can be used to treat type 2 diabetes by reversing insulin resistance, one of the main hallmarks of the disease. While TZDs were extremely popular in the 1990’s and early 2000’s, they have fallen out of use among physicians in recent decades because they were discovered to cause unwanted side effects, including weight gain and excess fluid accumulation in body tissues. (Source: World Pharma News)
Source: World Pharma News - April 11, 2024 Category: Pharmaceuticals Tags: Featured Research Research and Development Source Type: news

Study Assuages Thyroid Cancer Fears With GLP-1 Receptor Agonists
(MedPage Today) -- A Scandinavian cohort study suggested a popular class of diabetes drug did not put patients at an elevated risk for thyroid cancer, a longtime lingering concern with this drug class. Compared with DPP-4 inhibitors, patients... (Source: MedPage Today Nephrology)
Source: MedPage Today Nephrology - April 10, 2024 Category: Urology & Nephrology Source Type: news

Why a New Study Dubbed India the ‘Cancer Capital of the World’
A new study has unveiled an alarming picture of declining overall health in India. The report, released by the Indian multinational healthcare group, Apollo Hospitals, found that skyrocketing cases of cancer and other non-communicable diseases across the country have now made it “the cancer capital of the world.” [time-brightcove not-tgx=”true”] Despite reporting more than a million new cases every year, India’s cancer rate has not yet surpassed countries like Denmark, Ireland, and Belgium, which record some of the highest cancer rates in the world. It is also currently lower than the U.S....
Source: TIME: Health - April 10, 2024 Category: Consumer Health News Authors: Astha Rajvanshi Tags: Uncategorized India Source Type: news

Prevalence of Type 1 Diabetes Steady in Youth, Adults
WEDNESDAY, April 10, 2024 -- Nearly four in every 1,000 U.S. youths and five in every 1,000 U.S. adults reported having type 1 diabetes from 2019 through 2022, according to a research letter published online April 4 in the Journal of the... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - April 10, 2024 Category: Pharmaceuticals Source Type: news

Why So Many Women Are Waiting Longer to Have Kids
In 1970, the average woman in the U.S. had her first baby at around 21 years old. That’s hard to imagine now: new federal data published in April show that in 2022, the average first-time mother was a little older than 27—a record high for the country, and a sign of a major demographic change. This shift has been underway for years. Teenagers and women in their early 20s are having fewer kids, while the opposite is happening among older age groups. In 2022, for the seventh year in a row, the birth rate among U.S. women in their early 30s was higher than the rate among those in their late 20s. Perhaps even mo...
Source: TIME: Health - April 10, 2024 Category: Consumer Health News Authors: Jamie Ducharme Tags: Uncategorized healthscienceclimate Source Type: news

Severe Hospitalised Hypoglycaemia Rates Drop But Remain High Severe Hospitalised Hypoglycaemia Rates Drop But Remain High
In both diabetes types, socioeconomic deprivation was associated with higher rates of severe hypoglycaemia.Medscape UK (Source: Medscape Diabetes Headlines)
Source: Medscape Diabetes Headlines - April 10, 2024 Category: Endocrinology Tags: Diabetes & Endocrinology Clinical Summary Source Type: news

What Treatment Reduces Cardiac Risk in Hyperthyroidism? What Treatment Reduces Cardiac Risk in Hyperthyroidism?
Patients with hyperthyroidism had a lower risk for deadly cardiovascular events after surgery or radioactive iodine than those with ATDs, found a national cohort study.Medscape Medical News (Source: Medscape Diabetes Headlines)
Source: Medscape Diabetes Headlines - April 10, 2024 Category: Endocrinology Tags: Diabetes & Endocrinology Source Type: news

Novo Nordisk's Stock Could Get Another Boost, Thanks to This Huge Development
Novo Nordisk (NYSE: NVO) has become one of the most valuable healthcare stocks in the world, largely due to a couple of exceptional drugs, Ozempic and Wegovy. While the former is a diabetes drug and the latter is approved for weight loss, consumers have been using both to help lose weight. And…#novonordisk #nvo #ozempicandwegovy #wegovyformedicare #cvshealth #kaiserpermanente #medicare #fda #wegovy #denmark (Source: Reuters: Health)
Source: Reuters: Health - April 10, 2024 Category: Consumer Health News Source Type: news

Is taking statins making my diabetes worse? Dr Rosemary Leonard reveals answer
A reader with type-2 diabetes is no longer able to control her blood sugar through diet alone and asks the Express GP if statins may be the reason for this (Source: Daily Express - Health)
Source: Daily Express - Health - April 10, 2024 Category: Consumer Health News Source Type: news

Ozempic, Wegovy Won't Boost Thyroid Cancer Risk: Study
WEDNESDAY, April 10, 2024 -- Wegovy, Ozempic and other drugs known as GLP-1 analogues have become wildly popular for controlling diabetes and helping folks lose weight. There were concerns that longer term use of the drugs might raise users ' odds... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - April 10, 2024 Category: General Medicine Source Type: news